Ipamorelin
A ghrelin-mimetic growth hormone secretagogue often paired with CJC-1295 in research-market discussions.
Also appears in: Muscle Growth
This name primarily lives in the research market and should not be read like an approved pharmaceutical product.
Primary lane: Growth Hormone. Also surfaces under Muscle Growth for browsing and discovery.
No major aliases are tracked for this profile yet.
No FDA label signal · 2 trials · 43 PubMed results
What ipamorelin is
Ipamorelin is a growth hormone secretagogue that is usually discussed as a ghrelin-mimetic peptide. It commonly appears in the same conversations as CJC-1295 because the two are frequently described together in growth-hormone optimization stacks.
Why it matters
It is one of the most recognizable non-approved entries in the growth-hormone peptide category, so it helps anchor the library for readers trying to understand that corner of the market.
Regulatory context
Ipamorelin is not FDA-approved as a peptide medicine in the United States. On PeptideBenchmark it is categorized as research-market, not approved therapy.
Practical reading note
If a page talks about ipamorelin as if it were standard wellness medicine, that is usually a sign the regulatory context is being blurred.